• TT (↓), beta-hemoglobin (↑), ApoA-1 (↓), and transferrin (↓)in early-stage OC • When combined with CA125, biomarkers should significantly improve the detection of early stage ovarian cancer. This evidence concerns the gene APOA1 and ovarian carcinoma.